Search research articles
Contact Us
Filters
Showing results (31-40 of 105) with videos related to
Page
of 11
Sort By:
Transplantation and Cellular Therapy
|
June 30, 2022
Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis
Craig W Freyer, Daria V Babushok, Noelle V Frey, et al.
Plos One
|
April 6, 2019
Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia
Taylor Linaburg, Adam R Davis, Noelle V Frey, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 21, 2023
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant
Lindsey Chippendale, Craig W Freyer, Alison Carulli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 3, 2013
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation
Anita J Kumar, Elizabeth O Hexner, Noelle V Frey, et al.
The Journal of Clinical Investigation
|
June 15, 2023
RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia
Jian-Gang Ren, Bowen Xing, Kaosheng Lv, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group
Craig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning
Ran Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2018
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial
Ran Reshef, Alex Ganetsky, Edward P Acosta, et al.
Investigational New Drugs
|
April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition
Margaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 30, 2015
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation
Lijun Meng, Zhenjiang Bai, Shan He, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 105) with videos related to
Sort By:
Page
of 11
Transplantation and Cellular Therapy
|
June 30, 2022
Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis
Craig W Freyer, Daria V Babushok, Noelle V Frey, et al.
Plos One
|
April 6, 2019
Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia
Taylor Linaburg, Adam R Davis, Noelle V Frey, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
August 21, 2023
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant
Lindsey Chippendale, Craig W Freyer, Alison Carulli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 3, 2013
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation
Anita J Kumar, Elizabeth O Hexner, Noelle V Frey, et al.
The Journal of Clinical Investigation
|
June 15, 2023
RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia
Jian-Gang Ren, Bowen Xing, Kaosheng Lv, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 13, 2018
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group
Craig R Soderquist, Mark D Ewalt, David R Czuchlewski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2014
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning
Ran Reshef, Elizabeth O Hexner, Alison W Loren, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 14, 2018
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial
Ran Reshef, Alex Ganetsky, Edward P Acosta, et al.
Investigational New Drugs
|
April 3, 2018
Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition
Margaret T Kasner, Rosemarie Mick, Grace R Jeschke, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 30, 2015
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation
Lijun Meng, Zhenjiang Bai, Shan He, et al.
Page
of 11